Cargando…

Systematic review and meta‐analysis of genomic alterations in acral melanoma

Acral melanoma (AM) tumors arise on the palms, soles, fingers, toes, and nailbeds. A comprehensive systematic meta‐analysis of AM genomic aberrations has not been conducted to date. A literature review was carried out to identify studies sequencing AM. Whole‐genome/exome data from 181 samples were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Broit, Natasa, Johansson, Peter A., Rodgers, Chloe B., Walpole, Sebastian T., Hayward, Nicholas K., Pritchard, Antonia L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540316/
https://www.ncbi.nlm.nih.gov/pubmed/35229492
http://dx.doi.org/10.1111/pcmr.13034
_version_ 1784803684171907072
author Broit, Natasa
Johansson, Peter A.
Rodgers, Chloe B.
Walpole, Sebastian T.
Hayward, Nicholas K.
Pritchard, Antonia L.
author_facet Broit, Natasa
Johansson, Peter A.
Rodgers, Chloe B.
Walpole, Sebastian T.
Hayward, Nicholas K.
Pritchard, Antonia L.
author_sort Broit, Natasa
collection PubMed
description Acral melanoma (AM) tumors arise on the palms, soles, fingers, toes, and nailbeds. A comprehensive systematic meta‐analysis of AM genomic aberrations has not been conducted to date. A literature review was carried out to identify studies sequencing AM. Whole‐genome/exome data from 181 samples were identified. Targeted panel sequencing data from MSK‐IMPACT were included as a validation cohort (n = 92), and studies using targeted hot spot sequencing were also collated for BRAF (n = 26 studies), NRAS (n = 21), and KIT (n = 32). Statistical analysis indicated BRAF, NRAS, PTEN, TYRP1, and KIT as significantly mutated genes. Frequent copy‐number aberrations were also found for important cancer genes, such as CDKN2A, KIT, MDM2, CCND1, CDK4, and PAK1, among others. Mapping genomic alterations within the context of the hallmarks of cancer identified four components frequently altered, including (i) sustained proliferative signaling and (ii) evading growth suppression, (iii) genome instability and mutation, and (iv) enabling replicative immortality. This analysis provides the largest analysis of genomic aberrations in AM in the literature to date and highlights pathways that may be therapeutically targetable.
format Online
Article
Text
id pubmed-9540316
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95403162022-10-14 Systematic review and meta‐analysis of genomic alterations in acral melanoma Broit, Natasa Johansson, Peter A. Rodgers, Chloe B. Walpole, Sebastian T. Hayward, Nicholas K. Pritchard, Antonia L. Pigment Cell Melanoma Res Original Articles Acral melanoma (AM) tumors arise on the palms, soles, fingers, toes, and nailbeds. A comprehensive systematic meta‐analysis of AM genomic aberrations has not been conducted to date. A literature review was carried out to identify studies sequencing AM. Whole‐genome/exome data from 181 samples were identified. Targeted panel sequencing data from MSK‐IMPACT were included as a validation cohort (n = 92), and studies using targeted hot spot sequencing were also collated for BRAF (n = 26 studies), NRAS (n = 21), and KIT (n = 32). Statistical analysis indicated BRAF, NRAS, PTEN, TYRP1, and KIT as significantly mutated genes. Frequent copy‐number aberrations were also found for important cancer genes, such as CDKN2A, KIT, MDM2, CCND1, CDK4, and PAK1, among others. Mapping genomic alterations within the context of the hallmarks of cancer identified four components frequently altered, including (i) sustained proliferative signaling and (ii) evading growth suppression, (iii) genome instability and mutation, and (iv) enabling replicative immortality. This analysis provides the largest analysis of genomic aberrations in AM in the literature to date and highlights pathways that may be therapeutically targetable. John Wiley and Sons Inc. 2022-03-07 2022-05 /pmc/articles/PMC9540316/ /pubmed/35229492 http://dx.doi.org/10.1111/pcmr.13034 Text en © 2022 The Authors. Pigment Cell & Melanoma Research published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Broit, Natasa
Johansson, Peter A.
Rodgers, Chloe B.
Walpole, Sebastian T.
Hayward, Nicholas K.
Pritchard, Antonia L.
Systematic review and meta‐analysis of genomic alterations in acral melanoma
title Systematic review and meta‐analysis of genomic alterations in acral melanoma
title_full Systematic review and meta‐analysis of genomic alterations in acral melanoma
title_fullStr Systematic review and meta‐analysis of genomic alterations in acral melanoma
title_full_unstemmed Systematic review and meta‐analysis of genomic alterations in acral melanoma
title_short Systematic review and meta‐analysis of genomic alterations in acral melanoma
title_sort systematic review and meta‐analysis of genomic alterations in acral melanoma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540316/
https://www.ncbi.nlm.nih.gov/pubmed/35229492
http://dx.doi.org/10.1111/pcmr.13034
work_keys_str_mv AT broitnatasa systematicreviewandmetaanalysisofgenomicalterationsinacralmelanoma
AT johanssonpetera systematicreviewandmetaanalysisofgenomicalterationsinacralmelanoma
AT rodgerschloeb systematicreviewandmetaanalysisofgenomicalterationsinacralmelanoma
AT walpolesebastiant systematicreviewandmetaanalysisofgenomicalterationsinacralmelanoma
AT haywardnicholask systematicreviewandmetaanalysisofgenomicalterationsinacralmelanoma
AT pritchardantonial systematicreviewandmetaanalysisofgenomicalterationsinacralmelanoma